2019
Mendelian randomization provides support for obesity as a risk factor for meningioma
Takahashi H, Cornish AJ, Sud A, Law PJ, Disney-Hogg L, Calvocoressi L, Lu L, Hansen HM, Smirnov I, Walsh KM, Schramm J, Hoffmann P, Nöthen MM, Jöckel KH, Schildkraut JM, Simon M, Bondy M, Wrensch M, Wiemels JL, Claus EB, Turnbull C, Houlston RS. Mendelian randomization provides support for obesity as a risk factor for meningioma. Scientific Reports 2019, 9: 309. PMID: 30670737, PMCID: PMC6343031, DOI: 10.1038/s41598-018-36186-6.Peer-Reviewed Original ResearchConceptsRisk of meningiomaMeningioma riskObesity-related traitsLipoprotein cholesterolBlood pressureRisk factorsOdds ratioLow-density lipoprotein cholesterolHigh-density lipoprotein cholesterolMendelian randomizationCause of meningiomaGenetic instrumentsDiastolic blood pressureEpidemiological observational studiesSystolic blood pressureBody mass indexBody fat percentageWaist circumferenceTotal cholesterolMass indexObservational studyMeningioma patientsMeningiomasBasal metabolic rateObesity
2010
Comparison of anthropometric indices of obesity in predicting subsequent risk of hyperglycemia among Chinese men and women in Mainland China.
Xu F, Wang YF, Lu L, Liang Y, Wang Z, Hong X, Li J. Comparison of anthropometric indices of obesity in predicting subsequent risk of hyperglycemia among Chinese men and women in Mainland China. Asia Pacific Journal Of Clinical Nutrition 2010, 19: 586-93. PMID: 21147722.Peer-Reviewed Original ResearchConceptsBody mass indexWaist circumferencePotential confoundersChinese adultsCommunity-based prospective cohort studyOverall cumulative incidenceProspective cohort studyStrong risk factorCapillary blood glucoseDose-response relationshipPerformance of waistSubsequent hyperglycemiaCohort studyCumulative incidenceMass indexHip ratioSuch dose-response relationshipsAnthropometric indicesBlood glucoseRisk factorsSubsequent riskRelative riskWHtRHyperglycemiaChinese men